Moderna Teams With IBM To Explore AI, Quantum Computing In Vaccine Development

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, has announced its collaboration with IBM. The two companies are joining forces to explore the potential of artificial intelligence (AI), quantum computing and other advanced technologies in vaccine development.
The partnership will leverage IBM’s expertise in AI, cloud computing and quantum computing to help Moderna accelerate its research into mRNA-based treatments for infectious diseases like COVID-19. By combining their respective capabilities, the two companies aim to develop innovative solutions that can speed up drug discovery processes while improving accuracy and precision.
IBM’s Watson Health Cloud platform will be used by Moderna scientists as they work on developing vaccines against emerging infectious diseases such as SARS-CoV-2. This platform provides access to powerful analytics tools that can analyze large datasets quickly and accurately, enabling researchers to identify patterns or trends more easily than ever before. Additionally, IBM is providing access to its Quantum Experience cloud service which allows users to experiment with real quantum computers from anywhere in the world via an internet connection.
This collaboration marks an important step forward in leveraging cutting edge technology for medical research purposes; it could potentially revolutionize how we approach vaccine development going forward by allowing us to make faster progress towards finding effective treatments for various illnesses at scale. It also highlights the importance of public-private partnerships when it comes tackling global health challenges like pandemics – something that has become increasingly evident during this current crisis period where governments have had limited resources available due their own budgetary constraints or lack thereof altogether..
By working together on this project, both companies hope they can make meaningful contributions towards advancing healthcare innovation worldwide – ultimately leading us closer towards achieving our collective goal of creating healthier societies around the globe through better prevention methods and improved treatment options for those affected by disease outbreaks such as COVID-19..
Moderna Teams With IBM To Explore AI, Quantum Computing In Vaccine Development | Moderna Teams With IBM To Explore AI, Quantum Computing In Vaccine Development | Technology | MarketWatch